References
- IwaseASuzukiYAraieMThe prevalence of primary open-angle glaucoma in Japanese: the Tajimi StudyOphthalmology20041111641164815350316
- YamamotoTIwaseAAraieMThe Tajimi Study Report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese populationOphthalmology20051121661166916111758
- HeijlALeskeMCBengtssonBReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol20021201268127912365904
- Agis InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS InvestigatorsAm J Ophthalmol200013042944011024415
- LeskeMCHeijlAHusseinMFactors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma TrialArch Ophthalmol2003121485612523884
- Collaborative Normal Tension Glaucoma Study GroupComparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressuresAm J Ophthalmol19981264874979780093
- SuzukiKAn update review of medical treatment in normal-tension glaucomaAtarashi Iganka2016333543
- TomidokoroAClinical application of glaucoma medicationsFolia Pharmacol Jpn2006128255258
- MarquisREWhitsonJTManagement of glaucoma: focus on pharmacological therapyDrugs Aging200522121
- KuwayamaYKomemushiSTafluprost Multi-center Study GroupIntraocular pressure lowering effect of 0.0015% tafluprost as compared to placebo in patients with normal tension glaucoma: randomized, double–blind, multicenter, phase III studyNippon Ganka Gakkai Zasshi201011443644320545217
- KuwayamaYNomuraAProspective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safetyAdv Ther20143146147124615289
- KuwayamaYHashimotoMKakegawaRNomuraAShimadaFProspective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: effectiveness and treatment persistenceAdv Ther2017341411142528502035
- KosekiNAraieMYamagamiJShiratoSYamamotoSEffects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressureJ Glaucoma1999811712310209728
- TomitaGAraieMKitazawaYTsukaharaSA three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patientsEye20041898498915037889
- MengNZhangPHuangHColor Doppler imaging analysis of retrobulbar blood flow velocities in primary open-angle glaucomatous eyes: a meta-analysisPLoS One20138e6272323675419
- TsudaSYokoyamaYChibaNEffect of topical tafluprost on optic nerve head blood flow in patients with myopic disc typeJ Glaucoma20132239840323552835
- KojimaSSugiyamaTShibataMUekiMKomotoRIkedaTChanges in visual field, morphology and microcirculation of the optic nerve head after instillation of tafluprost for one yearJpn J Clin Ophthalmol201468895902
- ChauhanBCGarway-HeathDFGoniFJPractical recommendations for measuring rates of visual field change in glaucomaBr J Ophthalmol20089256957318211935
- KashiwagiKFuruyaTPersistence with topical glaucoma therapy among newly diagnosed Japanese patientsJpn J Ophthalmol201458687424408788